Xiaofeng Wang

12.1k citations

77 papers · 3.8k indexed · h-index 29

Impact in

Pathology and Forensic Medicine top 1%
- Cancer Mechanisms and Therapy
Molecular Biology top 2%
- Chromatin Remodeling and Cancer
- Genomics and Chromatin Dynamics
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Heat shock proteins research
- RNA modifications and cancer

Papers in

Molecular Biology 62
- Chromatin Remodeling and Cancer 14
- RNA modifications and cancer 8
- Genomics and Chromatin Dynamics 6
- Protein Degradation and Inhibitors 6
- RNA and protein synthesis mechanisms 5
- Heat shock proteins research 5
Cancer Research 13
- MicroRNA in disease regulation 5

Co-authors: Charles W.M. Roberts Jeffrey R. Haswell Katherine Helming Xiaomin Song Peter J. Park Yan Fu B. Alver Boris G. Wilson
Journals: Cancer Research (5 papers)Clinical Cancer Research (3 papers)Nature Communications (2 papers)Journal of Biological Chemistry (2 papers)Biochemical Journal (2 papers)
Partner nations: China United States Canada

In The Last Decade

Xiaofeng Wang

74 papers receiving 3.7k citations

Peers

Countries citing papers authored by Xiaofeng Wang

Since Specialization

Citations

This map shows the geographic impact of Xiaofeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Wang more than expected).

Fields of papers citing papers by Xiaofeng Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Wang. The network helps show where Xiaofeng Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Xiaofeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xiaofeng Wang Line = papers co-authored together Xiaofeng Wang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comprehensive Analyses of Single-Cell and Bulk RNA Sequencing Data From M2 Macrophages to Elucidate the Immune Prognostic Signature in Patients with Gastric Cancer Peritoneal Metastasis ImmunoTargets and Therapy ·王云菊, Liang Tang, Xiaofeng Wang, Yongxin Zhang, Wenwei Liu, Panagiotis Bernardakis, Oesterr Statist Zentralamt, Yuanchen Ma, А.П. Анісімов, Song Wu	2025	0
2	Regulatory mechanisms of the Hippo/YAP axis by G-protein coupled estrogen receptor in gastric signet-ring cell carcinoma Neoplasia ·Yu-Fei Wang, 真一大西, M. Hirata, Emma Bloch, Xiaofeng Wang, Ana Marcela Barragan, رضا حسن ابراهیم, Longgang Wang, Luguang Liu, Bing Liu, 毛灿月, 明彦中島, Michel Anne, Peter Wolberink, Ahmad Alsarraf	2025	1
3	Cleavage Under Targets and Release Using Nuclease (CUT&RUN) of Epigenetic Regulators Methods in molecular biology ·Y.H. Cho, Xiaofeng Wang	2024	1
4	RBP Image Database: A resource for the systematic characterization of the subcellular distribution properties of human RNA binding proteins Nucleic Acids Research ·Louis Philip Benoit Bouvrette, Xiaofeng Wang, Jonathan Boulais, Jian Kong, P Sopp, Steven M. Blue, Lijun Zhan, Sara Olson, Rebecca Stanton, Xintao Wei, Brian A. Yee, Eric L. Van Nostrand, Xiang‐Dong Fu, Christopher B. Burge, Brenton R. Graveley, G Yeo, Éric Lécuyer	2022	2
5	ARID4B is critical for mouse embryonic stem cell differentiation towards mesoderm and endoderm, linking epigenetics to pluripotency exit Journal of Biological Chemistry ·Cosmescu Alexandru, Jialiang Huang, Josip Golomejić, Xiaofeng Wang, 昌呉世, Fei Chen, Stuart H. Orkin	2020	12
6	BRD9 defines a SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors Nature Communications ·Xiaofeng Wang, Su Wang, Emma C. Troisi, Thomas P. Howard, Jeffrey R. Haswell, Oi Kuan Choong, 권용준, Pilar Ramos, Elaine M. Oberlick, Evgeni P. Tzvetkov, Franck Morell, Francisca Vázquez, William C. Hahn, Peter J. Park, Charles W.M. Roberts	2019	137
7	Indolyl-chalcone derivatives induce hepatocellular carcinoma cells apoptosis through oxidative stress related mitochondrial pathway in vitro and in vivo Chemico-Biological Interactions ·P Randriambololondrantomalala, Mengya Wang, J. P. Bruwer, Di Wang, Xin Li, Xiaofeng Wang, Wei‐Wei Liao, (unknown)	2018	13
8	The SWI/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers Nature Communications ·B. Alver, Kimberly H. Kim, Ping Lu, Xiaofeng Wang, Haley E. Manchester, Weishan Wang, Jeffrey R. Haswell, Peter J. Park, Charles W.M. Roberts	2017	260
9	SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation Nature Genetics ·Xiaofeng Wang, Ryan S. Lee, B. Alver, Jeffrey R. Haswell, Su Wang, Jakub Mieczkowski, Yotam Drier, Shawn Gillespie, Tenley C. Archer, Jennifer N. Wu, Evgeni P. Tzvetkov, Emma C. Troisi, Scott L. Pomeroy, Jaclyn A. Biegel, Michael Tolstorukov, B Bernstein, Peter J. Park, Charles W.M. Roberts	2016	239
10	ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice Nature Genetics ·Radhika Mathur, B. Alver, Adrianna K. San Roman, Boris G. Wilson, Xiaofeng Wang, Agoston T. Agoston, Peter J. Park, Ramesh A. Shivdasani, Charles W.M. Roberts	2016	242
11	GPCRserver: an accurate and novel G protein-coupled receptor predictor Molecular BioSystems ·Renxiang Yan, Xiaofeng Wang, Lanqing Huang, Jun Lin, Maxime Durisotti, Ziding Zhang	2014	10
12	Prediction of outer membrane proteins by combining the position- and composition-based features of sequence profiles Molecular BioSystems ·Renxiang Yan, Jun Lin, Zhen Chen, Xiaofeng Wang, Lanqing Huang, Maxime Durisotti, Ziding Zhang	2014	3
13	Adjuvant treatment with disodium cantharidinate and vitamin B6 injection for patients with hepatocellular carcinoma: a Meta analysis based on randomized controlled trials Xiaofeng Wang, Paul M. Farmer	2014	2
14	The Analysis of Small Molecule Metabolite Profiles in the Blood as a Biomarker of Lung Cancer CHEST Journal ·Peter J. Mazzone, Xiaofeng Wang, Abd el Rahman Abd el gaber, Qi Zhang, G. Jun, Robert Mahoney, Haiyuan Shi, Kirk L. Pappan	2014	1
15	The CXCL12–CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis Clinical Cancer Research ·Wei Zhuo, Lin Jia, Nan Song, Xin‐an Lu, Yanping Ding, Xiaofeng Wang, Xiaomin Song, Yan Fu, Yongzhang Luo	2012	95
16	Tumor-Associated Macrophages Promote Angiogenesis and Melanoma Growth via Adrenomedullin in a Paracrine and Autocrine Manner Clinical Cancer Research ·Peiwen Chen, Yujie Huang, J. J. Bade, Yanping Ding, Nan Song, Xiaofeng Wang, Xiaomin Song, Yongzhang Luo	2011	172
17	The Regulatory Mechanism of Extracellular Hsp90α on Matrix Metalloproteinase-2 Processing and Tumor Angiogenesis Journal of Biological Chemistry ·Xiaomin Song, Xiaofeng Wang, Wei Zhuo, Hubing Shi, Dan Feng, Yi Sun, Yun Liang, Yan Fu, Ana Carolina Guimarães Padula, Yongzhang Luo	2010	99
18	NFAT1 Mediates Placental Growth Factor-Induced Myelomonocytic Cell Recruitment via the Induction of TNF - α The Journal of Immunology ·Yanping Ding, Yujie Huang, Nan Song, Xiaobin Gao, Shaopeng Yuan, Xiaofeng Wang, Hongchen Cai, Yan Fu, Yongzhang Luo	2010	23
19	The regulatory mechanism of Hsp90α secretion and its function in tumor malignancy Proceedings of the National Academy of Sciences ·Xiaofeng Wang, Xiaomin Song, Wei Zhuo, Yan Fu, Hubing Shi, Yun Liang, Maomeng Tong, Guodong Chang, Yongzhang Luo	2009	218
20	Abstract #5649: Pharmakokinetic/phamacodynamic relationship of the HSP90 inhibitor NVP-AUY922 in human xenografts and patients in a clinical Phase I trial Cancer Research ·Michael Rugaard Jensen, Susan Ide, Josef Brueggen, Joseph Schoepfer, Xiaofeng Wang, Cornelia Quadt, Carlos Garcı́a-Echeverrı́a	2009	2

About Xiaofeng Wang

Xiaofeng Wang is a scholar working on Molecular Biology, Cancer Research, Pathology and Forensic Medicine, Developmental Neuroscience and Cellular and Molecular Neuroscience, having authored 77 papers that have together received 3.8k indexed citations. Recurring topics across this work include Chromatin Remodeling and Cancer (14 papers), Cancer Mechanisms and Therapy (13 papers), RNA modifications and cancer (8 papers), Genomics and Chromatin Dynamics (6 papers), Protein Degradation and Inhibitors (6 papers), RNA and protein synthesis mechanisms (5 papers), Heat shock proteins research (5 papers) and MicroRNA in disease regulation (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (919 citations), Molecular Biology (3.0k citations), Cancer Research (560 citations), Immunology (512 citations) and Oncology (606 citations). Xiaofeng Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Charles W.M. Roberts, Jeffrey R. Haswell, Katherine Helming, Xiaomin Song, Peter J. Park, Yan Fu, B. Alver, Boris G. Wilson, Wei Zhuo and Yongzhang Luo. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Nature Communications, Journal of Biological Chemistry and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact